Geisinger’s goal is to be not just one of the top health care organizations, but one of top organizations among all the companies in the United States.
Give away healthy breakfasts and dinners to people with diabetes and it will help them control their disease.
They take the brakes off the immune system so it attacks cancer cells. But many people don’t respond to checkpoint inhibitors, so researchers are looking for ways to defeat the resistance.
Despite standardization, advocates for various industries and certain patient needs continue to propose changes in coverage rules. Much of the advocacy is occurring at the state level with a focus on pharmaceutical coverage, such as equalizing cost sharing between oral and infused oncology drugs or setting limits on cost sharing for prescriptions.
At last count, the pharmaceutical industry’s new product pipeline included more than 7,000 products in late-stage development, roughly half of which are deemed “specialty.” The reality is, our health care system is poorly equipped to address this issue head-on.
Too many Americans are skipping prescribed medications because they find them too expensive. That foretells trouble for payers—and for patients. On this page, you’ll find several relevant facts and numbers.
Cancer survivors were better able to afford care and did not see delays in treatment from 2010 through 2016, the years when the ACA was phased in. But researchers were unable to make a definite connection because many of the ACA’s coverage changes did not come about until January 2014.
A British study of 296,535 people added to evidence that the so-called obesity paradox—that being overweight or obese does not necessarily mean a greater chance of getting a heart attack—simply does not exist. Many of us could stand to lose a few pounds to lower our cardiovascular risk.
Health care is increasingly becoming like other retail encounters—a transaction between buyers and sellers. Patients, providers, payers—everybody needs to adjust. With the right technology and the will to change, the process of paying for health care can become as simple—and as painless—as getting a haircut.
Current asthma guidelines combine treatment, follow-up, and re-evaluation to manage asthma control, reduce impairment, and decrease risk of morbidity in patients. Analysis reveals that FeNO monitoring to guide asthma management is cost effective, increasing quality-adjusted life years while decreasing costs associated with asthma management.
Are we seeing the beginning of the end of the independent physician? Between July 2015 and July 2016, U.S. hospitals bought up 5,000 independent physician practices. In 2012, about 14% of practices were owned by hospitals. Four years later, that percentage had more than doubled to 29%.
Compared with control groups, the SGLT-2 inhibitors and GLP-1 agonists were associated with reductions in all-cause mortality—and researchers had set all-cause mortality as the primary outcome for the meta-analysis. As for the DPP-4 inhibitors, they identified an association with a small increase (0.1%) in all-cause mortality compared with controls.